Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to evaluate the efficacy of rTMS targeting the anterior cingulate cortex, another stimulation site that may be effective in the treatment of neuropathic pain, and to compare it with motor cortex stimulation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| active rTMS primer motor cortex | Active Comparator |
| |
| rTMS anterior cingulate gyrus | Experimental |
| |
| sham rTMS primer motor cortex | Sham Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| active TMS | Device | Patients in the active or sham primary motor cortex rTMS group will receive active or sham rTMS at 5 Hz targeting the M1 area of the lower extremity motor area under medical supervision for a total of 10 sessions over 2 weeks. Patients in the active anterior cingulate cortex rTMS group will also receive active 5 Hz rTMS targeting the anterior cingulate cortex for a total of 10 sessions over 2 weeks under medical supervision. |
| Measure | Description | Time Frame |
|---|---|---|
| visual analog scale | The assessment of pain using a 10 cm visual analogue scale (VAS), separately for daytime and night-time. The assessment will be conducted on a scale of "0 = no pain" to "10 = the most severe pain imaginable". | first day of treatment, at the end of treatment (at 2nd week), 4 week after end of treatment, 12 week after end of treatment |
| Measure | Description | Time Frame |
|---|---|---|
| neuropathic pain scale | first day of treatment, at the end of treatment (at 2nd week), 4 week after end of treatment, 12 week after end of treatment | |
| Beck Depression Scale | first day of treatment, at the end of treatment (at 2nd week), 4 week after end of treatment, 12 week after end of treatment |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ayşe Naz Kalem Özgen, specialist | Contact | +90 0312 797 00 00 | kalemnaz@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ankara Etlik City Hospital | Recruiting | Ankara | Yenimahalle | 06010 | Turkey (Türkiye) |
Not provided
| ID | Term |
|---|---|
| D013119 | Spinal Cord Injuries |
| D009437 | Neuralgia |
| ID | Term |
|---|---|
| D013118 | Spinal Cord Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D020196 | Trauma, Nervous System |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| sham TMS | Device | Patients in the active or sham primary motor cortex rTMS group will receive active or sham rTMS at 5 Hz targeting the M1 area of the lower extremity motor area under medical supervision for a total of 10 sessions over 2 weeks. Patients in the active anterior cingulate cortex rTMS group will also receive active 5 Hz rTMS targeting the anterior cingulate cortex for a total of 10 sessions over 2 weeks under medical supervision. |
|
| 5-point Likert scale | It is a 5-point Likert scale to be used for assessing patient satisfaction. | first day of treatment, at the end of treatment (at 2nd week), 4 week after end of treatment, 12 week after end of treatment |
| Gaziler Physical Therapy and Rehabilitation Training and Research Hospital | Recruiting | Ankara | Çankaya | 06800 | Turkey (Türkiye) |
|
| D014947 | Wounds and Injuries |
| D010523 | Peripheral Nervous System Diseases |
| D009468 | Neuromuscular Diseases |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |